跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Sobistal-650 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Sobistal-650
Approved
STANDARD
Sobistal-650
Stallion Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
0e4222432728674e
Company
Stallion Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
0e4222432728674e
Drug Approval Philippines Name
Sobistal-650
Product Name
Sobistal-650
Registration Number
DRP-16642
Brand Name
Sobistal-650
Generic Name
Sodium Bicarbonate.
Dosage Form
Film-Coated Tablet
Dosage Strength
650 mg
Manufacturer
Stallion Laboratories Pvt. Ltd.
Importer
Ambica International Corporation
Distributor
Ambica International Corporation
Issuance Date
29 May 2025
Expiry Date
29 May 2030
Pharmacologic Category
Antacid
Classification
Over-the-Counter (OTC) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
0e4222432728674e
Type
Standard
Back to Philippines FDA Approvals